Clinical Trials
All Clinical Trials - Page 27 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03684642Phase 3Terminated
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Dulaglutide
- NCT03672604Phase 1Completed
A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
Exenatide
- NCT03631186N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)
Semaglutide
- NCT03671733Phase 3Unknown
Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
Liraglutide
- NCT03260881Phase 4Completed
Liraglutide Effects on Epicardial Fat Inflammatory Genes
Liraglutide
- NCT03672812Phase 3Completed
The Use of Liraglutide in Brain Death
Liraglutide
- NCT03684824N/AUnknown
Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment
Gonadorelin
- NCT03361735Phase 2Active Not Recruiting
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
Gonadorelin
- NCT03648281N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)
Semaglutide
- NCT03341429Phase 4Completed
Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response
Liraglutide
- NCT03632759EARLY_Phase 1Completed
Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
Liraglutide
- NCT03659578Phase 2Completed
Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer
Thymosin-Alpha-1
- NCT03611322Phase 1Completed
A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)
Semaglutide
- NCT03541928Phase 2Unknown
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
Gonadorelin
- NCT03611582Phase 3Completed
Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program
Semaglutide
- NCT04500743N/ACompleted
Role of Suppression of Endometriosis With Progestins Before IVF-ET
Gonadorelin
- NCT03662958N/AUnknown
Comparison of a Novel Leuprolide With Market Leuprolide
Gonadorelin
- NCT04555850Phase 1Completed
A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers
TB-500
- NCT03591718Phase 1Completed
A Study to Test Different Doses of BI 456906 in Patients With Obesity
Survodutide
- NCT03600480Phase 1Completed
A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
Semaglutide
- NCT03598621Phase 1Completed
A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools
Semaglutide
- NCT03560336N/ACompleted
A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.
Liraglutide
- NCT03298087Phase 2Completed
Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
Gonadorelin
- NCT03436654Phase 2Active Not Recruiting
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
Gonadorelin
- NCT03557268N/ACompleted
Pubertal Blockade and Hormone Therapy in Transgender Youth
Gonadorelin
- NCT03574584Phase 1Completed
A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese
Semaglutide
- NCT03543059N/AUnknown
A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients
Gonadorelin
- NCT03571594Phase 1Terminated
A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers
Ghrp-6
- NCT03500484EARLY_Phase 1Terminated
Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
Liraglutide
- NCT03456687Phase 1Completed
Effects of Exenatide on Motor Function and the Brain
Exenatide
- NCT03548987Phase 3Completed
Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
Semaglutide
- NCT03548935Phase 3Completed
STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
Semaglutide
- NCT03150511Phase 2Recruiting
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
Tesamorelin
- NCT01422096EARLY_Phase 1Withdrawn
Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
Gonadorelin
- NCT05946148N/ACompleted
Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)
Dulaglutide
- NCT03555994Phase 2Completed
A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
Liraglutide
- NCT03419234Phase 2Active Not Recruiting
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Gonadorelin
- NCT03479762N/ACompleted
In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database
Liraglutide
- NCT03498001N/ACompleted
Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
Semaglutide
- NCT03361969Phase 2Completed
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.
Gonadorelin
- NCT03270709Phase 1Terminated
Effect of High-Dose Vitamin D3 in Smokers and Non-Smokers With and Without HIV
Ll-37
- NCT03495102Phase 3Completed
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
Dulaglutide
- NCT03463252Phase 2/Phase 3Recruiting
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
Gonadorelin
- NCT04268927Phase 2Unknown
Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET
Gonadorelin
- NCT03482024Phase 1Completed
A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function
Tirzepatide
- NCT03457012N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice
Semaglutide
- NCT02473406Phase 4Completed
Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis
Thymosin-Alpha-1
- NCT03486392Phase 2Completed
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
Liraglutide
- NCT03519178Phase 1/Phase 2Terminated
A Study of PF-06873600 in People With Cancer
Gonadorelin
- NCT03347890Phase 4Completed
Reward Mechanisms in Obesity
Liraglutide